Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries – ReliefWeb
- Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries ReliefWeb
- Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost STAT
- Gilead signs lenacapavir access deal; Arvinas CEO to step down Yahoo
- Gilead partners with the Global Fund to support Yeztugo access strategy on heels of FDA nod Fierce Pharma
- FDA Approves First Twice‑Yearly HIV Prevention Injection bet.com